OP
JAZZ icon

Oslo Pensjonsforsikring’s Jazz Pharmaceuticals JAZZ Stock Holding History

Oslo Pensjonsforsikring’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-908
Closed -$96.9K – 468
2024
Q2 		$96.9K Buy
+908
New +$99.8K 0.01% 296

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Oslo Pensjonsforsikring's JAZZ Position: Q3 2024 in Review

Oslo Pensjonsforsikring sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2024, closing a stake of 908 shares — an estimated $96.9K sold.

Oslo Pensjonsforsikring first reported a position in JAZZ in Q2 2024 and held it in 1 quarter. The position peaked at $96.9K in Q2 2024. 478 funds tracked by Wall St. Rank hold JAZZ as of Q3 2024.

  • Oslo Pensjonsforsikring reported no remaining Jazz Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Oslo Pensjonsforsikring sold 908 Jazz Pharmaceuticals shares in Q3 2024, an estimated $96.9K.
  • Oslo Pensjonsforsikring first reported a position in Jazz Pharmaceuticals in Q2 2024 and held it in 1 quarter.
  • Oslo Pensjonsforsikring's Jazz Pharmaceuticals position peaked at $96.9K in Q2 2024.
  • 478 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2024.

Based on Oslo Pensjonsforsikring's 13F filing for Q3 2024, filed 13 Oct 2026.